Finance

Beta
Lists
SHJBF:OTCMKTS
Shanghai Junshi Biosciences Co Ltd
$3.35
0.00%
(0.00) 1D
May 11, 9:38:20 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SHJBF...
Mkt. cap
31.96B
Avg. vol.
33.00
Volume
0.00
52-wk high
$4.23
52-wk low
$2.99
Beta
-0.74
Shares outstanding
260.30M
No. of employees
3K
Mkt. cap
31.96B
Avg. vol.
33.00
Volume
0.00
52-wk high
$4.23
52-wk low
$2.99
Beta
-0.74
Shares outstanding
260.30M
No. of employees
3K
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to SHJBF in the past 3 months
Strong Buy
Buy
3
Hold
0
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for SHJBF in the last 3 months.
Highest
Current HK$3.35
HK$32.90 (+882.09%)
Average
HK$32.17 (+860.30%)
Lowest
HK$31.60 (+843.28%)
News stories
From sources across the web
About Shanghai Junshi Biosciences Co Ltd
CEOLi Ning
Employees2.9K
FoundedDec 27, 2012
Headquarters-
SectorBiotechnology
Websitejunshipharma.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
667.79M
637.50M
692.54M
726.29M
Cost of goods sold
156.45M
99.14M
181.49M
146.98M
Cost of revenue
156.45M
99.14M
181.49M
146.98M
Research and development expenses
355.00M
276.58M
359.97M
282.50M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
359.77M
395.70M
469.25M
390.41M
Operating expense
717.45M
649.14M
844.36M
671.44M
Total operating expenses
873.90M
748.27M
1.03B
818.42M
Operating income
-206.11M
-110.78M
-333.31M
-92.13M
Other non operating income
3.59M
-38.69M
48.03M
-28.52M
EBT including unusual items
-198.37M
-207.18M
-330.88M
-37.84M
EBT excluding unusual items
-218.35M
-151.70M
-322.39M
-16.35M
Income tax expense
7.71M
1.45M
4.20M
5.58M
Effective tax rate
-3.89%
-0.70%
-1.27%
-14.75%
Other operating expenses
2.14M
-26.58M
19.58M
-4.67M
Net income
-177.82M
-183.00M
-279.47M
-20.56M
Net profit margin
-26.63%
-28.71%
-40.35%
-2.83%
Earnings per share
-
-
-
-
Interest and investment income
6.26M
8.75M
9.46M
128.29M
Interest expense
-21.89M
-11.18M
-24.89M
-23.99M
Net interest expenses
-15.62M
-2.43M
-15.43M
104.30M
Depreciation and amortization charges
-
-
-
-
EBITDA
-140.99M
-45.87M
-267.97M
-26.79M
Gain or loss from assets sale
-7.58M
7.58M
-35.26M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer